babyÖ±²¥app

CU Boulder biochemistry student Tamanna Talwar explored the barriers to early diagnosis and treatment of children with Autism Spectrum Disorder

Briana Aboulache and Karolin Luger win Howard Hughes Medical Institute Gilliam fellowship, which looks to build a more inclusive scientific environment

Dr. Hannah E. Ledvina, a postdoctoral fellow in Dr. Aaron Whiteley’s lab in the Biochemistry Department, is a recipient of the 2021 Jane Coffin Childs Memorial Postdoctoral Fellowship. This prestigious award was first established in 1937 and aims to support cutting edge medical research at the early career level. Each...

Look deep inside the brain of someone with Alzheimer’s disease, most forms of dementia or the concussion-related syndrome known as chronic traumatic encephalopathy (CTE) and you’ll find a common suspected culprit: stringy, hairball-like tangles of a protein called tau.

For nearly one year, a group of scientists and volunteers from across the university has met seven days a week, often sleeping just a few hours a night, to bring students back to campus safely.

Researchers at the University of babyÖ±²¥app Boulder have won a $1.2 million award to establish a Center for Light Sheet Microscopy and Data Science, the Arnold and Mabel Beckman Foundation has announced.

Some of the most commonly used drugs for treating hereditary breast and ovarian cancers may not work the way we thought they did, according to new CU Boulder research .

Sabrina L. Spencer, assistant professor of biochemistry and member of the BioFrontiers Institute at the University of babyÖ±²¥app Boulder, is one of five new winners of a 2021 Damon Runyon-Rachleff Innovation Award, the Damon Runyon Cancer Research Foundation announced recently . She is also one of seven new winners of...

Dr. David Goeddel is former head of Genentech’s microbiology department, CU Biochemistry alum Class of ‘77, and the scientist behind the first commercially viable insulin biosynthesis pipeline in human history. Today, Dr. Goeddel continues to drive innovation as a managing partner of The Column Group , a venture capitalist firm...

Dr. Peter H. Seeberger is the Director of the Max Planck Institute of Colloids and Interfaces in Berlin, a position he has held since 2009. He earned his Ph.D. in biochemistry from the University of babyÖ±²¥app under Distinguished Professor Marvin Caruthers. Dr. Seeberger has helped to start nine companies that...